Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed/Refractory B-cell Malignancies
Beijing, Beijing Municipality
Relapsed/Refractory B-cell Malignancies Clinical Trials in Beijing, Beijing Municipality
1 recruiting
Beijing, Beijing Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University
30 enrolled
6 locations
NCT07002112
Feedback